Literature DB >> 1676047

The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies.

A Casadevall1, M D Scharff.   

Abstract

Cryptococcus neoformans is a ubiquitous fungus that can cause serious infections in humans. The fungus has a polysaccharide (C. neoformans capsular polysaccharide; CNPS) capsule that contributes to its pathogenicity and can elicit an antibody response. Nevertheless, only 4 of 60 BALB/c mice chronically infected with C. neoformans had a detectable increase in serum anti-CNPS. The sera of three responder mice contained both IgM and IgG anti-CNPS antibody, and the titers of lambda and kappa anti-CNPS antibody were approximately equal. Eight IgM and one IgG3 monoclonal antibodies (mAbs) were generated from the spleen of one responder mouse, and one IgA was generated from the spleen of another mouse. Seven of the IgMs, the IgG3, and the IgA mAb had lambda light chains and were specific for serotype D CNPS. Molecular analysis confirmed that this was a highly restricted antibody response. All of the D-specific antibodies used VH441, JH3, and either V lambda 2/J lambda 2 or V lambda 1/J lambda 1, and all had the same heavy chain CDR3 amino acid sequence, even though there were differences in the nucleotide sequence of the N/D segment. One IgM mAb reacted with both serotype A and D CNPS, and this mAb used different VH and JH genetic elements and had kappa light chains. All the anti-CNPS mAbs used J proximal VH gene elements that have previously been shown to bind dextran and other polysaccharides. Sequence and Southern blot analysis indicate that the serotype-D CNPS-specific mAbs arose from only a few precursor B cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1676047      PMCID: PMC2118886          DOI: 10.1084/jem.174.1.151

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  44 in total

Review 1.  Regulation of magnitude of antibody response to bacterial polysaccharide antigens by thymus-derived lymphocytes.

Authors:  P J Baker
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

Review 2.  Regulation of the assembly and expression of variable-region genes.

Authors:  G D Yancopoulos; F W Alt
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

3.  Molecular dissection of the murine antibody response to streptococcal group A carbohydrate.

Authors:  C T Lutz; T L Bartholow; N S Greenspan; R J Fulton; W J Monafo; R M Perlmutter; H V Huang; J M Davie
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

4.  Cryptococcus neoformans antibody levels in patients with AIDS.

Authors:  F Dromer; P Aucouturier; J P Clauvel; G Saimot; P Yeni
Journal:  Scand J Infect Dis       Date:  1988

5.  Oral dextran sulfate (UA001) in the treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.

Authors:  D I Abrams; S Kuno; R Wong; K Jeffords; M Nash; J B Molaghan; R Gorter; R Ueno
Journal:  Ann Intern Med       Date:  1989-02-01       Impact factor: 25.391

6.  Genetic control of the humoral response to cryptococcal capsular polysaccharide in mice.

Authors:  F Dromer; P Yeni; J Charreire
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

7.  Serologic grouping of Cryptococcus neoformans.

Authors:  D E Wilson; J E Bennett; J W Bailey
Journal:  Proc Soc Exp Biol Med       Date:  1968-03

8.  T15 PC-binding monoclonal antibodies retain specificity when they switch from IgM to IgG.

Authors:  G Spira; H L Aguila; M D Scharff
Journal:  J Immunol       Date:  1988-04-15       Impact factor: 5.422

9.  Fc region-dependence of IgG3 anti-streptococcal group A carbohydrate antibody functional affinity. I. The effect of temperature.

Authors:  N S Greenspan; D A Dacek; L J Cooper
Journal:  J Immunol       Date:  1988-12-15       Impact factor: 5.422

10.  Glycosylation of a VH residue of a monoclonal antibody against alpha (1----6) dextran increases its affinity for antigen.

Authors:  S C Wallick; E A Kabat; S L Morrison
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more
  53 in total

1.  Dysregulation in IL-12 secretion by neutrophils from HIV-infected patients.

Authors:  A Vecchiarelli; C Monari; B Palazzetti; F Bistoni; A Casadevall
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia.

Authors:  Fabio Ghiotto; Franco Fais; Angelo Valetto; Emilia Albesiano; Shiori Hashimoto; Mariella Dono; Hideyuki Ikematsu; Steven L Allen; Jonathan Kolitz; Kanti R Rai; Marco Nardini; Anna Tramontano; Manlio Ferrarini; Nicholas Chiorazzi
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

3.  Evidence for preferential Ig gene usage and differential TdT and exonuclease activities in human naïve and memory B cells.

Authors:  Cuixia Tian; Grace K Luskin; Kevin M Dischert; James N Higginbotham; Bryan E Shepherd; James E Crowe
Journal:  Mol Immunol       Date:  2006-12-29       Impact factor: 4.407

4.  Production of agglutinating monoclonal antibody against antigen 8 specific for Cryptococcus neoformans serotype D.

Authors:  R Ikeda; S Nishimura; A Nishikawa; T Shinoda
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

5.  Molecular and idiotypic analyses of the antibody response to Cryptococcus neoformans glucuronoxylomannan-protein conjugate vaccine in autoimmune and nonautoimmune mice.

Authors:  G Nussbaum; S Anandasabapathy; J Mukherjee; M Fan; A Casadevall; M D Scharff
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

6.  Organ-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infection.

Authors:  J Rivera; M Feldmesser; M Cammer; A Casadevall
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

7.  Antibodies raised against chlamydial lipopolysaccharide antigens reveal convergence in germline gene usage and differential epitope recognition.

Authors:  Cory L Brooks; Sven Müller-Loennies; Svetlana N Borisova; Lore Brade; Paul Kosma; Tomoko Hirama; C Roger Mackenzie; Helmut Brade; Stephen V Evans
Journal:  Biochemistry       Date:  2010-01-26       Impact factor: 3.162

8.  Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody.

Authors:  D L Goldman; S C Lee; A Casadevall
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains.

Authors:  J Mukherjee; M D Scharff; A Casadevall
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis.

Authors:  S C Lee; A Casadevall; D W Dickson
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.